Background
==========

Obesity is associated with substantial technical difficulties and increased patient morbidity after open gastrectomy \[[@B1],[@B2]\]. The body-mass index (BMI) has been widely used as an indicator of the extent of obesity in patients \[[@B1]-[@B3]\]. However, the BMI does not always accurately reflect the volume of visceral fat, because the distribution of fatty tissue differs greatly between individuals \[[@B4]\].

Recently, several techniques have been developed to assess the volume of visceral fat. In terms of reproducibility and accuracy, computed tomography (CT) is considered to be the optimal technique for assessing visceral fat \[[@B5]\] compared with alternatives such as ultrasonography \[[@B6]\], magnetic-resonance imaging \[[@B7]\] and other anthropometric measurements \[[@B8],[@B9]\].

Several studies have shown that the visceral fat area (VFA) determined from a single scan at the level of the umbilicus is closely correlated with the total volume of visceral fat \[[@B10],[@B11]\]. The VFA might therefore accurately reflect the extent of obesity in patients.

Few previous reports have evaluated the association between the VFA and technical difficulties during gastrectomy with D2 lymph-node dissection for gastric cancer. To address this issue, we examined the influence of the VFA on gastrectomy with D2 lymph-node dissection.

Methods
=======

Between January 2005 and March 2007, 100 consecutive patients with a preoperative diagnosis of gastric cancer who underwent open gastrectomy with D2 lymph-node dissection at the Department of Surgery, Gastroenterological Centre, Yokohama City University, Japan, were enrolled in this study. In total, 61 patients underwent open distal gastrectomy (ODG) and 39 patients underwent open total gastrectomy (OTG). The participants comprised 72 men and 28 women, and were aged between 36 and 85 years (mean ± standard deviation (SD) = 66.0 ± 9.8 years). All of the patients were confirmed as having gastric adenocarcinoma following endoscopic biopsies. All of the patients also underwent a barium-swallow study and CT scans. Patient data were retrieved from operative and pathological reports.

The staging and definition of lymph nodes were principally based on the Japanese Classification of Gastric Carcinoma (JGC) \[[@B12]\]. Experienced pathologists were employed to ensure a high quality of pathological diagnosis. Surgery was performed after all of the possible alternative procedures and treatments had been explained to each patient, and informed consent had been obtained.

All of the patients underwent D2 lymph-node dissection of gastric cancer, as defined by the JGC. The standard reconstruction methods were Billroth I gastroduodenostomy after ODG and Roux-en-Y oesophagojejunostomy after OTG. In total, 50 patients underwent gastrectomy using the LigaSure^TM^ Atlas (Valleylab, Boulder, CO) to seal all of the lymphatic ducts and vessels without suture ligation (the LigaSure group). The remaining 50 patients underwent gastrectomy using the conventional surgical approach, in which most of the lymphatic ducts and vessels were ligated with sutures (the non-LigaSure group).

To assess the influence of BMI on open gastrectomy, the patients were classified into two groups: a high BMI group (BMI ≥ 25 kg/m^2^; *n*= 21) and a normal BMI group (BMI \<25 kg/m^2^; *n*= 79). The patient characteristics, intraoperative parameters and postoperative parameters were compared between the two groups.

The mean intraoperative blood loss (IBL) was 345.2 ± 273.7 ml. To assess the influence of obesity on open gastrectomy, the patients were divided into two groups according to IBL: a high IBL group (IBL ≥ 300 ml; *n*= 42) and a low IBL group (IBL \<300 ml; *n*= 58). The patient characteristics, intraoperative parameters and postoperative parameters were compared between the two groups.

The patients were also classified into two groups based on the VFA in accordance with the Japan Society for the Study of Obesity \[[@B13]\]: a high VFA group (≥ 100 cm^2^; *n*= 34) and a normal VFA group (\<100 cm^2^; *n*= 66).

Logistic regression analysis was performed to evaluate the risk factors for high IBL.

Fat volume
----------

The subcutaneous fat area (SFA) and the VFA were preoperatively measured (both in cm^2^) using a cross-sectional CT scan at the level of the umbilicus by FatScan software version 3 (N2 systems Inc., Osaka, Japan; Figure [1](#F1){ref-type="fig"}).

![**Distribution of abdominal fat as measured by FatScan software on a CT scan at the umbilicus level.** The visceral fat area was regarded as red, and the subcutaneous fat area was regarded as pink.](1754-9493-2-7-1){#F1}

Statistical analysis
--------------------

The SPSS program version 10.0 for Windows (SPSS Inc, Chicago, IL) was used for all statistical analyses. A Chi-square test was applied to evaluate the differences in the proportions of each variable. The Student\'s *t*-test was used to evaluate the continuous variables. All data are expressed as the mean ± SD. Logistic-regression analysis was performed to evaluate the predictive factors for high IBL using the following 10 variables: age (years); gender (male vs. female); tumour location (upper third vs. middle or lower third); macroscopic type (superficial vs. well-defined vs. ill-defined); tumour size (mm); histological type (differentiated vs. undifferentiated); lymph-node metastasis (N0 vs. N1 vs. N2 vs. N3); preoperative complications (absence vs. presence); LigaSure^TM^ Atlas (not used vs. used); and either BMI (low vs. high) or VFA (low vs. high). A *p*value \<0.05 was regarded as statistically significant.

Results
=======

Patient characteristics and BMI
-------------------------------

There were significant differences in the SFA and the VFA between the high BMI group and the normal BMI group. There were no differences in any other clinicopathological factors between these two groups (Table [1](#T1){ref-type="table"}).

###### 

Patient characteristics and BMI undergoing open gastrectomy with D2 lymph-node dissection for gastric cancer

                               High BMI (*n*= 21) (%)   Normal BMI (*n*= 79) (%)   *p*value
  ---------------------------- ------------------------ -------------------------- ----------
  Age (years)                  67.5 ± 6.0               65.6 ± 10.6                0.4361
  Gender                                                                           0.1153
   Male                        18 (85.7)                54 (68.4)                  
   Female                      3 (14.3)                 25 (31.6)                  
  SFA (cm^2^)                  155.2 ± 35.8             105.3 ± 53.4               0.0001
  VFA (cm^2^)                  155.0 ± 41.1             69.5 ± 41.7                \<0.0001
  Tumor location                                                                   0.5773
   U                           2 (9.5)                  10 (12.7)                  
   M                           12 (57.1)                35 (44.3)                  
   L                           7 (33.3)                 34 (43.0)                  
  Macroscopic type                                                                 0.6873
   Superficial                 6 (28.6)                 25 (31.6)                  
   Well-defined                9 (42.9)                 26 (32.9)                  
   Ill-defined                 6 (28.6)                 28 (35.4)                  
  Tumor size (mm)              50.1 ± 35.8              56.4 ± 27.9                0.3898
  Histological type                                                                0.9490
   Differentiated              11 (52.4)                42 (53.2)                  
   Undifferentiated            10 (47.6)                37 (46.8)                  
  Depth of invasion                                                                0.5844
   T1                          5 (23.8)                 28 (41.2)                  
   T2                          9 (42.9)                 16 (23.5)                  
   T3                          7 (33.3)                 24 (35.3)                  
  Lymph-node metastasis                                                            0.4651
   N0                          7 (33.3)                 28 (40.0)                  
   N1                          9 (42.9)                 27 (38.6)                  
   N2                          5 (23.8)                 12 (17.1)                  
   N3                          0 (0)                    3 (4.3)                    
  Stage                                                                            0.5214
   IA                          4 (19.0)                 18 (22.8)                  
   IB                          4 (19.0)                 18 (22.8)                  
   II                          3 (14.3)                 19 (24.1)                  
   IIIA                        6 (28.6)                 11 (13.9)                  
   IIIB                        3 (14.3)                 6 (7.6)                    
   IV                          1 (4.8)                  7 (8.9)                    
  Preoperative complications                                                       0.9055
   Absence                     12 (57.1)                44 (55.7)                  
   Presence                    9 (42.8)                 35 (44.3)                  
  LigaSure Atlas                                                                   0.4614
   Used                        12 (57.1)                38 (48.1)                  
   Not used                    9 (42.9)                 41 (51.9)                  
  Operative procedure                                                              0.5091
   Distal gastrectomy          8 (53.3)                 53 (62.4)                  
   Total gastrectomy           7 (46.7)                 32 (37.6)                  
  Splenectomy                                                                      0.9817
   Absence                     16 (76.2)                60 (75.9)                  
   Presence                    5 (23.8)                 19 (24.1)                  

BMI = body-mass index; SFA = subcutaneous fat area; VFA = visceral fat area;

P \< .05 was considered statistically significant

Surgical outcomes and BMI
-------------------------

The IBL was significantly greater in the high BMI group than in the normal BMI group. By contrast, the operating time, the number of dissected lymph nodes and the morbidity did not differ between the two groups. No hospital death occurred among the patients (Table [2](#T2){ref-type="table"}).

###### 

Surgical outcomes and BMI undergoing open gastrectomy with D2 lymph-node dissection for gastric cancer

                                    High BMI (*n*= 21) (%)   Normal BMI (*n*= 79) (%)   *p*value
  --------------------------------- ------------------------ -------------------------- ----------
  Operating time (min)              262.7 ± 83.6             245.4 ± 77.9               0.3752
  Estimated blood loss (ml)         454.9 ± 303.0            316.0 ± 259.7              0.0381
  Number of dissected lymph nodes   33.7 ± 11.8              37.9 ± 18.8                0.3316
  Morbidity                                                                             0.1673
   Absence                          16 (76.2)                70 (88.6)                  
   Presence                         5 (23.8)                 9 (11.4)                   
  Hospital death                    0                        0                          1.0000

BMI = body-mass index; P \< .05 was considered statistically significant

Patient characteristics and IBL
-------------------------------

The patient age was significantly greater (*p*= 0.0318) in the high IBL group than in the low IBL group. The BMI and the VFA were significantly greater (*p*= 0.0308 and *p*= 0.0106, respectively) in the high IBL group than in the low IBL group. The tumour location, the operative procedure and the incidence of splenectomy differed significantly (*p*= 0.002, *p*= 0.0015 and *p*\<0.0001, respectively) between the two groups. There were no differences in any other clinicopathological factors (Table [3](#T3){ref-type="table"}).

###### 

Patient characteristics and IBL undergoing open gastrectomy with D2 lymph-node dissection for gastric cancer

                               High IBL (*n*= 42) (%)   Low IBL (*n*= 58) (%)   *p*value
  ---------------------------- ------------------------ ----------------------- ----------
  Age (years)                  68.5 ± 8.1               64.2 ± 10.6             0.0318
  Gender                                                                        0.4271
   Male                        32 (76.2)                40 (70.0)               
   Female                      10 (23.8)                18 (30.0)               
  BMI (kg/m^2^)                                                                 0.0100
   \<25                        28 (66.7)                51 (87.9)               
   ≥25                         14 (33.3)                7 (12.1)                
  VFA (cm^2^)                                                                   0.0041
   \<100                       21 (50.0)                45 (77.6)               
   ≥100                        21 (50.0)                13 (22.4)               
  SFA (cm2)                    123.1 ± 53.6             110.5 ± 54.2            0.2530
  Tumor location                                                                0.0020
   U                           10 (23.8)                2 (3.4)                 
   M/L                         32 (76.2)                56 (96.6)               
  Macroscopic type                                                              0.8455
   Superficial                 14 (33.3)                17 (29.3)               
   Well-defined                15 (35.7)                20 (34.5)               
   Ill-defined                 13 (31.0)                21 (36.2)               
  Tumor size (mm)              60.8 ± 33.2              51.0 ± 26.3             0.1016
  Histological type                                                             0.3589
   Differentiated              20 (47.6)                33 (56.9)               
   Undifferentiated            22 (52.4)                25 (43.1)               
  Depth of invasion                                                             0.1134
   T1                          12 (28.6)                21 (36.2)               
   T2                          20 (47.6)                16 (27.6)               
   T3                          10 (23.8)                21 (36.2)               
  Lymph-node metastasis                                                         0.1364
   N0                          15 (35.7)                29 (50.0)               
   N1                          16 (38.1)                20 (34.4)               
   N2                          8 (19.0)                 9 (15.5)                
   N3                          3 (7.1)                  0 (0)                   
  Stage                                                                         0.3351
   IA                          8 (19.0)                 14 (24.1)               
   IB                          7 (16.7)                 15 (25.9)               
   II                          11 (26.2)                11 (19.0)               
   IIIA                        6 (14.3)                 11 (19.0)               
   IIIB                        4 (9.5)                  5 (8.6)                 
   IV                          6 (9.5)                  2 (3.4)                 
  Preoperative complications                                                    0.8447
   Absence                     24 (57.1)                32 (55.2)               
   Presence                    18 (42.9)                18 (31.0)               
  LigaSure Atlas                                                                0.1050
   Used                        17 (40.5)                33 (56.9)               
   Not used                    25 (59.5)                25 (43.1)               
  Operative procedure                                                           0.0015
   Distal gastrectomy          24 (57.1)                43 (74.1)               
   Total gastrectomy           18 (42.9)                15 (25.9)               
  Splenectomy                                                                   \<0.0001
   Absence                     24 (57.1)                52 (89.7)               
   Presence                    18 (42.9)                6 (10.3)                

IBL = intraoperative blood loss; BMI = body-mass index; SFA = subcutaneous fat area; VFA = visceral fat area;

P \< .05 was considered statistically significant

Surgical outcomes and IBL
-------------------------

The operating time was significantly longer in the high IBL group than in the low IBL group. By contrast, the number of dissected lymph nodes and morbidity did not differ between the two groups. Hospital death was not observed among the patients (Table [4](#T4){ref-type="table"}).

###### 

Surgical outcomes and IBL undergoing open gastrectomy with D2 lymph-node dissection for gastric cancer

                         High IBL (*n*= 42) (%)   Low IBL (*n*= 58) (%)   *p*value
  ---------------------- ------------------------ ----------------------- ----------
  Operating time (min)   291.9 ± 87.4             218.1 ± 55.0            \<0.0001
  Dissected lymph node   37.1 ± 19.4              36.9 ± 16.4             0.9454
  Morbidity                                                               0.5131
   Absence               35 (83.3)                51 (87.9)               
   Presence              7 (16.7)                 7 (12.1)                
  Hospital death         0                        0                       1.0000

IBL = intraoperative blood loss; P \< .05 was considered statistically significant

Predictive factors for high IBL
-------------------------------

Univariate analysis revealed that patient age, high BMI, high VFA, gastric cancer in the upper third of the stomach, operative procedure and use of splenectomy were associated with high IBL (Table [3](#T3){ref-type="table"}). The multivariate analysis including BMI (low vs. high) along with the other nine variables described above showed that patient age, operative procedure and high BMI independently affected high IBL (*p*= 0.033 and odds ratio (OR) = 1.057, *p*= 0.001 and OR = 4.735, and *p*= 0.011 and OR = 4.356, respectively; Table [5](#T5){ref-type="table"}). The multivariate analysis including VFA (low vs. high) along with the other nine variables described above showed that patient age, operative procedure and high VFA independently affected high IBL (*p*= 0.035 and OR = 1.055, *p*= 0.003 and OR = 4.071, and *p*= 0.015 and OR = 3.170, respectively; Table [6](#T6){ref-type="table"}).

###### 

Logistic regression analysis was performed to evaluate predictive factors for high IBL

  Variable              Coefficient   Odds ratio (95% CI)     *p*value
  --------------------- ------------- ----------------------- ----------
  Age                   0.055         1.057 (1.005--1.112)    0.033
  Operative procedure                                         
   TG/DG                1.555         4.735 (1.832--12.238)   0.001
  BMI (kg/m^2^)                                               
   ≥25/\<25             1.472         4.356 (1.399--13.563)   0.011

IBL = intraoperative blood loss; BMI = body-mass index; CI = confidence limits

P \< .05 was considered statistically significant

###### 

Logistic regression analysis was performed to evaluate predictive factors for high IBL

  Variable              Coefficient   Odds ratio (95% CI\*)   *p*value
  --------------------- ------------- ----------------------- ----------
  Age                   0.054         1.055 (1.004--1.109)    0.035
  Operative procedure                                         
   TG/DG                1.404         4.071 (1.626--10.193)   0.003
  VFA (cm^2^)                                                 
   ≧100/\<100           1.154         3.170 (1.251--8.033)    0.015

IBL = intraoperative blood loss; VFA = visceral fat area; CI = confidence limits

P \< .05 was considered statistically significant

Discussion
==========

This study revealed that a high BMI adversely affected the IBL, and that age, operative procedure and BMI or VFA independently affected high IBL in open gastrectomy with D2 lymph-node dissection.

Gastric cancer is one of the most common malignancies in Japan \[[@B14]\]. Dietary changes favouring Western-style eating habits have resulted in an increased rate of obesity in the Japanese population \[[@B13]\]. Surgeons have thus had more opportunities to treat obese patients with gastric cancer in recent years.

Surgeons often assume that obese patients will suffer from adverse effects with respect to the short-term surgical outcomes of gastric surgery. Several studies have discussed the influence of obesity on surgical morbidity in gastric surgery. Some reported that high BMI was associated with increased intraoperative and postoperative morbidity in open D2 gastrectomy \[[@B1],[@B2],[@B15]\]. By contrast, others reported that high BMI had no effect on undesirable surgical outcomes of open gastric surgery \[[@B16],[@B17]\].

The current study evaluated the surgical outcomes of open gastrectomy with D2 lymph-node dissection for gastric cancer according to BMI. High BMI had a significant adverse effect on the IBL, but not on the operating time, the number of dissected lymph nodes or the morbidity, owing to careful perioperative management. The volume of IBL was thought to be greater in the high BMI group because fatty tissue has more abundant blood vessels; leakage from the fatty tissue might thus have accounted for the relatively high blood loss. The morbidity, however, remained relatively low within the high BMI group.

The BMI represents both the SFA and the intraperitoneal fat area. A recent report revealed that the VFA/body surface area might be a more useful index than the BMI for predicting the technical difficulties involved in laparoscopic resection of rectosigmoid carcinoma \[[@B18]\]. However, to our knowledge, no previous reports have assessed the influence of VFA on the short-term surgical outcomes of open gastrectomy with D2 lymph-node dissection. The current study showed that patient age, operative procedure and BMI or VFA could independently predict high IBL. These results suggest that the VFA is a useful predictive factor for high IBL in open gastrectomy D2 lymph-node dissection. Moreover, the BMI might be superior to the VFA, because it is simpler to measure.

An excess of fatty tissue necessitates more complex lymph-node dissection and a larger cutting area, which can sometimes be associated with haemorrhaging. More delicate haemostatic manipulation is thus necessary in obese patients to reduce the volume of IBL.

Conclusion
==========

It will be necessary to perform operative manipulations more carefully in patients with high BMI or high VFA, and to develop new devices with better haemostatic functions, in order to reduce blood loss during D2 gastrectomy.
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